GENE ONLINE|News &
Opinion
Blog

RNA Editing
GSK Buys into Wave’s Oligonucleotide Program With $170 Million
2022-12-14
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
EdiGene Digs Into Cell Therapies with Arbor and Neukio Partnerships
2022-02-10
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
2021-09-17
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
Feng Zhang’s Team Engineer “Ultra-Compact” Cas-13 To Solve Packaging and Delivery Issues of RNA Editors
2021-09-05
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
Roche Bets on Shape’s RNA Editing Tech in $3B Gene Therapy Collab
2021-08-25
The 6 Companies Leading the Resurgence in RNA Editing R&D
2021-08-24
New Era in Precision Medicine? Introduction & Overview of RNA Editing
2021-08-23
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top